Author

J. Alcain

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Alfranca· 1 shared A. Balazs· 1 shared A. J. Auguste· 1 shared A. Varese· 1 shared C. D. Arevalo· 1 shared C. M. Calleja· 1 shared C. Pueblas Castro· 1 shared D. E. Alvarez· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Alfranca

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Combined Dendritic Cell And Anti-TIGIT Immunotherapy Potentiate Trail+ Memory NK Cells Against HIV-1 Infected Cells

I. S. Cerrillo, O. Popova, M. A. Lera, I. Tsukalov, M. C. Mirabent, I. Santos, L. G. Fraile, P. Fuentes, C. D. Arevalo, J. Alcain, N. S. Gaona, M. L. Diez, C. M. Calleja, A. Alfranca, M. Genesca, , E. Martin-Gayo

Combining dendritic cell stimulation with anti-TIGIT antibodies enhances memory NK cell cytotoxicity against HIV-1 infected CD4+ T cells in vitro and in vivo.

bioRxiv · Apr 9, 2024 · PreprintImmunology

A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection.

L. M. Coria, L. M. Saposnik, C. Pueblas Castro, E. F. Castro, L. A. Bruno, W. B. Stone, P. S. Perez, M. L. Darriba, L. B. Chemes, J. Alcain, I. Mazzitelli, A. Varese, M. Salvatori, A. J. Auguste, D. E. Alvarez, , J. Cassataro

This paper evaluates RBD-based vaccine formulations with different adjuvants, finding that U-Omp19+Alum significantly increases neutralizing antibodies, B cells, and provides protection against SARS-CoV-2.

bioRxiv · Dec 7, 2021 · PreprintImmunology